5.95
Neogen Corp stock is traded at $5.95, with a volume of 4.47M.
It is down -1.49% in the last 24 hours and up +8.18% over the past month.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
See More
Previous Close:
$6.04
Open:
$6.09
24h Volume:
4.47M
Relative Volume:
0.73
Market Cap:
$1.29B
Revenue:
$912.20M
Net Income/Loss:
$-23.53M
P/E Ratio:
-51.74
EPS:
-0.115
Net Cash Flow:
$-124.88M
1W Performance:
+5.68%
1M Performance:
+8.18%
6M Performance:
+6.63%
1Y Performance:
-58.77%
Neogen Corp Stock (NEOG) Company Profile
Name
Neogen Corp
Sector
Industry
Phone
(517) 372-9200
Address
620 LESHER PLACE, LANSING
Compare NEOG with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
NEOG
Neogen Corp
|
5.95 | 1.31B | 912.20M | -23.53M | -124.88M | -0.115 |
![]()
TMO
Thermo Fisher Scientific Inc
|
524.58 | 198.17B | 43.21B | 6.58B | 6.17B | 17.28 |
![]()
DHR
Danaher Corp
|
205.14 | 144.97B | 24.01B | 3.41B | 4.86B | 4.7082 |
![]()
IDXX
Idexx Laboratories Inc
|
633.32 | 49.29B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
138.23 | 38.73B | 6.79B | 1.22B | 1.09B | 4.2644 |
![]()
IQV
Iqvia Holdings Inc
|
203.77 | 33.69B | 15.70B | 1.24B | 2.01B | 6.9036 |
Neogen Corp Stock (NEOG) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-29-25 | Downgrade | William Blair | Outperform → Mkt Perform |
Dec-19-24 | Initiated | Guggenheim | Buy |
Jun-16-23 | Initiated | Wells Fargo | Overweight |
Nov-22-22 | Upgrade | William Blair | Mkt Perform → Outperform |
Jul-12-22 | Initiated | Piper Sandler | Neutral |
May-23-19 | Initiated | Guggenheim | Neutral |
Dec-05-17 | Resumed | ROTH Capital | Neutral |
Jul-14-17 | Initiated | CL King | Neutral |
Jun-05-14 | Initiated | William Blair | Mkt Perform |
Mar-31-11 | Upgrade | Hilliard Lyons | Underperform → Neutral |
Sep-25-09 | Reiterated | Roth Capital | Buy |
Jul-22-09 | Reiterated | Roth Capital | Buy |
Mar-20-09 | Reiterated | Roth Capital | Buy |
Jan-07-09 | Reiterated | Roth Capital | Buy |
Sep-25-08 | Reiterated | Roth Capital | Buy |
Jan-04-08 | Reiterated | Roth Capital | Buy |
Sep-28-07 | Reiterated | Roth Capital | Buy |
Jul-25-07 | Reiterated | Roth Capital | Buy |
Jul-09-07 | Reiterated | Roth Capital | Buy |
May-08-07 | Initiated | Susquehanna Financial | Positive |
View All
Neogen Corp Stock (NEOG) Latest News
Neogen : Transcript (2025 10 09 transcript fy26q1 earnings) - MarketScreener
Technical analysis overview for Neogen Corporation stock2025 Winners & Losers & Safe Entry Momentum Tips - newser.com
Price momentum metrics for Neogen Corporation explainedTrade Exit Summary & Weekly High Potential Alerts - newser.com
Inspire Investing LLC Acquires 46,753 Shares of Neogen Corporation $NEOG - MarketBeat
Neogen Corp. Stock Hits Day Low of $5.57 Amid Price Pressure - Markets Mojo
Neogen (NASDAQ:NEOG) Releases Earnings Results, Beats Expectations By $0.12 EPS - MarketBeat
Neogen (NASDAQ:NEOG) Shares Gap UpWhat's Next? - MarketBeat
Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know - Yahoo Finance
Neogen (NEOG): Losses Deepen 90.4% Annually, Market Discounts Turnaround Narrative - Yahoo Finance
Stock Traders Buy Large Volume of Call Options on Neogen (NASDAQ:NEOG) - MarketBeat
Neogen's (NEOG) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
Neogen Q1 Earnings Miss Estimates, Revenues Beat, Stock Climbs - Yahoo Finance
NEOG Q3 Deep Dive: Q3 Results, Guidance Reaffirmed, and Operational Turnaround in Focus - The Globe and Mail
Decoding Neogen Corp (NEOG): A Strategic SWOT Insight - GuruFocus
Neogen: Fiscal Q1 Earnings Snapshot - Connecticut Post
Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Animal Tester Neogen Sticks To Annual Forecast Despite Tariffs - Benzinga
Why Neogen (NEOG) Stock Is Trading Up Today - Yahoo Finance
Neogen Corp reports results for the quarter ended August 31Earnings Summary - TradingView
Earnings call transcript: Neogen beats Q1 2026 earnings expectations - Investing.com
Neogen Outpaces Estimates But Faces Lower Sales After Divestiture - Finimize
Neogen Q1 Adj. EPS Meets Estimates; Reaffirms FY26 Revenue Outlook; Stock Up 8.6% - Nasdaq
Neogen (NEOG) Q1 Earnings Lag Estimates - Yahoo Finance
Neogen Q1 FY26 slides: revenue dips but company maintains full-year outlook - Investing.com
Neogen Corp (NEOG) Reports Q1 EPS of $0.17, Beating Estimates; R - GuruFocus
Neogen (NASDAQ:NEOG) Exceeds Q3 Expectations, Stock Soars - Yahoo Finance
Neogen shares soar 12% as first quarter results top expectations By Investing.com - Investing.com Canada
Neogen shares soar 12% as first quarter results top expectations - Investing.com
Neogen earnings beat by $0.11, revenue topped estimates - Investing.com
Neogen Corporation Q1 2026 Financial Results - TradingView
Neogen Announces First-Quarter 2026 Results - Yahoo Finance
Neogen (NEOG) Q3 Earnings Report Preview: What To Look For - Barchart.com
Could Neogen's (NEOG) Renewed Equestrian Partnership Reveal More About Its Animal Health Strategy? - Yahoo Finance
Top Wall Street Forecasters Revamp Neogen Expectations Ahead Of Q1 Earnings - Benzinga
Neogen (NASDAQ:NEOG) Stock Price Down 6.4%Should You Sell? - MarketBeat
Can Neogen’s (NEOG) Renewed Equestrian Partnership Strengthen Its Position in Animal Health Solutions? - simplywall.st
Wall Street's Insights Into Key Metrics Ahead of Neogen (NEOG) Q1 Earnings - Yahoo Finance
Assessing Neogen (NEOG) Valuation After Recent Share Price Uptick - simplywall.st
Analysts Estimate Neogen (NEOG) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Neogen (NEOG) to Release Earnings on Thursday - MarketBeat
Neogen (NASDAQ:NEOG) Coverage Initiated at CJS Securities - MarketBeat
Neogen (NEOG): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Neogen (NEOG) Stock Trades Up, Here Is Why - Yahoo Finance
Will Neogen Corporation stock reach Wall Street targetsQuarterly Risk Review & Daily Risk Controlled Trade Plans - newser.com
Earnings visualization tools for Neogen CorporationOil Prices & Detailed Earnings Play Strategies - newser.com
Neogen Corporation (NASDAQ:NEOG) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
NEOG: CJS Securities Initiates Coverage with 'Market Perform' Ra - GuruFocus
What analysts say about Neogen Corporation NG2 stockTechnical Analysis Insights & Ride the Wave of Market-Beating Growth - earlytimes.in
Banque Pictet & Cie SA Has $9.01 Million Position in Neogen Corporation $NEOG - MarketBeat
Neogen extends partnership with US Equestrian Federation - Investing.com
Leading Animal Health Company Neogen Strengthens US Equestrian Partnership for Critical Horse Safety Programs - Stock Titan
Neogen Corp Stock (NEOG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Neogen Corp Stock (NEOG) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Jones Douglas Edward | Former COO |
Oct 07 '25 |
Option Exercise |
5.63 |
12,940 |
72,852 |
94,787 |
ADENT JOHN EDWARD | Former CEO |
Oct 07 '25 |
Option Exercise |
5.63 |
32,936 |
185,430 |
339,948 |
Woteki Catherine E | Director |
Oct 07 '25 |
Option Exercise |
5.63 |
2,071 |
11,660 |
15,315 |
Tobin James P | Director |
Oct 07 '25 |
Option Exercise |
5.63 |
2,071 |
11,660 |
39,545 |
RODRIGUEZ RAFAEL A | Director |
Oct 07 '25 |
Option Exercise |
5.63 |
2,071 |
11,660 |
17,019 |
Gupta Aashima | Director |
Oct 07 '25 |
Option Exercise |
5.63 |
2,071 |
11,660 |
23,988 |
Green Ronald D | Director |
Oct 07 '25 |
Option Exercise |
5.63 |
2,071 |
11,660 |
14,852 |
CAPELLO JEFFREY D | Director |
Oct 07 '25 |
Option Exercise |
5.63 |
2,071 |
11,660 |
28,700 |
BOREL JAMES C | Director |
Oct 07 '25 |
Option Exercise |
5.63 |
2,071 |
11,660 |
92,545 |
BOEHM WILLIAM T | Director |
Oct 07 '25 |
Option Exercise |
5.63 |
2,071 |
11,660 |
38,285 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):